4th Commercializing Clinically Validated DTx

The 4th Commercializing Clinically Validated Digital Therapeutics Summit returns in December of 2021 as the only industry-led meeting deep-diving on stakeholder alliance and partnership to accelerate DTx scalability, to enable building sustainable & viable business models.

Across 3 days covering extensive and valuable content, we will bring together expert speakers to share their data on case studies of lessons learnt and keys to success, as well as insights into venturing into effective partnerships. This will give you the tools to conquer your most crucial challenges and accelerate sustainable scalability and adoption of your digital therapeutic.

Whether you are a drug, med device or a DTx developer, this is your must-attend event in 2021. Hear from your peers’ journeys and lessons learned, and re-engage in the long awaited dialogue to generate clinical and RWE, in order to serve our patients in need beyond just a pill!

Speakers: Abhishek Shah, Co-Founder & CEO, Wellthy Therapeutics, Brendon Hale, Senior Principal Research Scientist, UnitedHealth Group, Chris Wasden, Head of HappifyDTx, Happify Health, Dario Motti, Global Principal Scientist, Digital Health Technologies, Roche, Edouard Gasser, Co-Founder & CEO, Tilak Healthcare, Everett Crosland, Chief Commercial Officer, Cognito Therapeutics, Ameya Phadke, Patient Non Pharma Solutions Leader, Chiesi Group, Andy Molnar, CEO, Digital Therapeutics Alliance, Joseph Perekupka, Chief Commercial Officer, Freespira, Josh Sackman, President & Co- Founder, AppliedVR, Shaheen Lakhan, Senior Vice President, Research & Development, Click Therapeutics, Theo Ahadome, Head of BD & Alliance Management, DTx, Happify Health, Bruce Elliot, Co-Founder & CEO, Memory Lane Games Limited, Jesaja Brinkmann, Co-Founder & CEO, Cara Care, Jonathan Schremp, Director of Digital Health Engagement, Banner Health, Matthew Bars, CEO, IntelliQuit-My Nicotine Test, Peter Hames, Co-Founder & CEO, Big Health, Renae Beaumont, Assistant Professor of Psychology in Clinical Psychiatry, Weill Cornell Medicine, Laurel Sweeney, Founder & Principal, Access Strategies LLC, Michael Fergusson, CEO, Ayogo, Naveed Ejaz, Director of Digital Therapeutics, MindMaze, Pierre Leurent, CEO, Voluntis

Others Details

Brochure https://go.evvnt.com/863502-2?pid=6581